Pfizer xStock
PFEX
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
PFEX (Pfizer xStock) is a real-world asset (RWA) tracker certificate issued by Backed Assets, designed to provide 1:1 tokenized exposure to Pfizer Inc. equity across multiple chains. Active development reflects platform-level vitality at xStocks (including an API v1 to v2 migration and ongoing changelog updates in March 2026), alongside continuous underlying corporate reporting from Pfizer. However, the token suffers from critical structural weaknesses: it exhibits extremely thin on-chain liquidity, near-zero 24-hour trading volume (~$88.84), a tiny holder base (35 holders), and no public smart contract security audits. Furthermore, token holders receive no corporate voting rights or direct legal claims against Pfizer Inc., concentrating total operational and redemption risk with the centralized issuer. No qualifying red-flag security exploits or regulatory enforcement actions were identified, but severe illiquidity and centralized counterparty dependency heavily constrain its investment profile.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Pfizer xStock (PFEX)
PFEX (Pfizer xStock) is a real-world asset (RWA) tracker certificate issued by Backed Assets under its xStocks product line. The token is designed to provide 1:1 tokenized exposure to the equity of Pfizer Inc., backed by real shares held by a regulated third-party custodian. Deployed across multiple blockchain networks—including Ethereum, Arbitrum One, BNB Chain, Solana, TON, and Mantle—PFEX enables fractional on-chain exposure to Pfizer stock without providing holders with corporate voting rights or direct legal claims against Pfizer Inc.
PFEX operates as a passive tokenized wrapper within the xStocks suite, where development activity is tracked at the platform level (such as an API v1 to v2 migration) alongside the corporate disclosures of Pfizer Inc. The product is offered through platforms such as Kraken and is redeemable through Backed. However, access is subject to geographical restrictions and is not available to users located in the United States.
Structurally, PFEX relies on a fully centralized issuer model, which introduces operational counterparty risk. The token suffers from extremely low market adoption and liquidity, reflecting a holder base of approximately 35 holders and near-zero daily trading volume. Furthermore, the token contracts lack public smart contract security audits and published off-chain reserve attestations. Despite these structural and liquidity limitations, no smart contract exploits, depegs, exchange delistings, or direct regulatory enforcement actions have been recorded against the token.